Promptly and ZEISS VisioGen Partner for AI-Verified Patient Engagement
Promptly and ZEISS VisioGen have partnered to integrate AI-driven patient engagement with human clinical review for ophthalmology practices.

Promptly and ZEISS VisioGen have announced a partnership aimed at enhancing patient engagement within ophthalmology practices through a combination of artificial intelligence and human oversight.
The collaboration connects all website inquiries received by a practice to a system that ensures licensed clinical review before proceeding. This ensures that patient booking, follow-up, and conversion processes are streamlined and managed effectively.
The new integrated solution intends to improve operational efficiency and patient experience by addressing common challenges such as response delays and administrative burdens. The technology leverages AI for initial processing while maintaining human clinical validation for accuracy and reliability.
Miami, Florida, October 8, 2026 – This partnership seeks to modernize patient interaction in the ophthalmology sector, ensuring timely and accurate communication from initial inquiry to appointment confirmation.